发明名称 RECOMBINANT ADENO-ASSOCIATED VIRUS-MEDIATED EXPRESSION OF FRACTALKINE FOR TREATMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES
摘要 Methods are described pertaining to the use of fractalkine (FKN, CX3CL1 ) and its receptor CX3CRI for treatment of neuroinflammation and/or neurodegeneration. Also included are methods for treatment of neuroinflammation and/or neurodegenerative diseases, comprising: administering to cells of a subject in need of such treatment, an adeno-associated virus that comprises a functional fractalkine gene operably linked to transcriptional control elements. The methods are used to treat or ameliorate Parkinson's disease, neuroinflammatory and/or neurodegenerative diseases including, but not limited to, Alzheimer's disease, epilepsy, aging, and traumatic brain injury.
申请公布号 WO2013006514(A3) 申请公布日期 2013.06.06
申请号 WO2012US45158 申请日期 2012.06.30
申请人 UNIVERSITY OF SOUTH FLORIDA;THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS;GEMMA, CARMELINA;BICKFORD, PAULA, C.;NASH, KEVIN, R.;MORGANTI, JOSH;BACHSTETTER, ADAM 发明人 GEMMA, CARMELINA;BICKFORD, PAULA, C.;NASH, KEVIN, R.;MORGANTI, JOSH;BACHSTETTER, ADAM
分类号 A61K39/00;A61K39/23 主分类号 A61K39/00
代理机构 代理人
主权项
地址